Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Denosumab Inj 60 mg/ml
DRUG
2 trials
Sponsors
Peter Vestergaard
, Thomas Nickolas, MD MS
Conditions
Kidney Transplant; Complications
Osteoporosis
Parathyroid Adenoma
Parathyroid Hyperplasia
Primary Hyperparathyroidism
Renal Osteodystrophy
Phase 2
The Effects of 12-months of Denosumab on Bone Density in Prevalent Kidney Transplant Recipients
Terminated
NCT03960554
Thomas Nickolas, MD MS
Kidney Transplant; Complications, Osteoporosis, Renal Osteodystrophy
Start: 2020-01-16
End: 2021-12-02
Updated: 2024-07-25
Phase 3
Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet.
Completed
NCT03027557
Peter Vestergaard
Parathyroid Adenoma, Parathyroid Hyperplasia, Primary Hyperparathyroidism
Start: 2017-03-01
End: 2019-09-12
Updated: 2021-05-25
Related Papers
Denosumab and cinacalcet for primary hyperparathyroidism (DENOCINA): a randomised, double-blind, placebo-controlled, phase 3 trial.
2020-05-01
45 citations